Literature DB >> 3243277

The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module.

R Schneider1, E Schneider-Scherzer, M Thurnher, B Auer, M Schweiger.   

Abstract

Immunological screening of a lambda gt11 library, constructed from HeLa mRNA, yielded several ribonuclease/angiogenin inhibitor (RAI) cDNA clones containing 900-bp inserts. Northern blot analysis revealed that the length of the RAI mRNA is approximately 1.9 kb. Construction and screening of a eukaryotic cDNA expression library (HeLa) containing preferentially complete cDNA inserts led to the isolation of a full length clone. The complete nucleotide sequence was determined. The C-terminal amino acid sequence deduced from the cDNA is identical to the peptide sequence obtained from a CNBr fragment of RAI, confirming the identity of the clone. The deduced primary structure of RAI consists of eight homologous tandem repeats with remarkable periodicity of leucine and cysteine residues. Each repeat is derived from the duplication of a leucine-rich 28-amino-acid module. This prototype module is closely related to a repetitive 24-amino-acid motif of unclear function, previously found in proteins involved in important biological processes such as blood coagulation, embryonic development, cell morphogenesis and signal transduction. Although homologous, the RAI modules show distinct differences in length and amino acid composition to the modules of this group of proteins, demonstrating their high potential of variability, necessary for adaptation to very diverse roles. Based on our results we propose that these repetitive modules are a common structural feature of a novel protein superfamily whose members exert their function by highly specific protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3243277      PMCID: PMC455125          DOI: 10.1002/j.1460-2075.1988.tb03310.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  39 in total

1.  Studies on cellular inhibitors of ribonuclease. III. The levels of ribonuclease and ribonucleases inhibitor during the regeneration of rat liver.

Authors:  K SHORTMAN
Journal:  Biochim Biophys Acta       Date:  1962-07-09

2.  Ribonuclease. V. Studies on the properties and distribution of ribonuclease inhibitor in the rat.

Authors:  J S ROTH
Journal:  Biochim Biophys Acta       Date:  1956-07

3.  The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence.

Authors:  J A Lopez; D W Chung; K Fujikawa; F S Hagen; E W Davie; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  [Effect of protein deprivation on the activity of rat liver ribonucleases and their inhibitor].

Authors:  C Quirin-Stricker; M Gross; P Mandel
Journal:  Biochim Biophys Acta       Date:  1968-04-24

5.  [Studies on the biosynthesis of proteins. VII. Activity of various desoxyribonucleic acids and ribonuclease inhibitors from rabbit reticulocytes in a cell-free protein synthesis system in Escherichia coli. DNA-dependent in vitro synthesis of "early proteins" of E. coliphages T4].

Authors:  P Traub; W Zillig; R L Millette; M Schweiger
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1965

6.  The variation in the activities of hepatic ribonuclease and ribonuclease inhibitor in chicken livers as a function of age.

Authors:  N K Sarkar
Journal:  Life Sci II       Date:  1970-06-22

7.  A suggested control function for the animal tissue ribonuclease-ribonuclease inhibitor system, based on studies of isolated cells and phytohaemagglutinin-transformed lymphocytes.

Authors:  N Kraft; K Shortman
Journal:  Biochim Biophys Acta       Date:  1970-09-17

8.  A possible role for ribonuclease in the regulation of protein synthesis in normal and hypophysectomized rats.

Authors:  E N Brewer; L B Foster; B H Sells
Journal:  J Biol Chem       Date:  1969-03-25       Impact factor: 5.157

9.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  Ribonuclease-inhibitor system abnormality in dystrophic mouse skeletal muscle.

Authors:  B W Little; W L Meyer
Journal:  Science       Date:  1970-11-13       Impact factor: 47.728

View more
  19 in total

1.  Self-association of CIITA and its transactivation potential.

Authors:  T J Sisk; S Roys; C H Chang
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  RYK, a receptor tyrosine kinase-related molecule with unusual kinase domain motifs.

Authors:  C M Hovens; S A Stacker; A C Andres; A G Harpur; A Ziemiecki; A F Wilks
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Novel brain-specific bovine cDNA for a developmentally regulated mRNA encoding a putative new member of the leucine-rich glycoprotein (LRG) family.

Authors:  E C Tan; L Lim
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

4.  The trypanosome leucine repeat gene in the variant surface glycoprotein expression site encodes a putative metal-binding domain and a region resembling protein-binding domains of yeast, Drosophila, and mammalian proteins.

Authors:  B L Smiley; A W Stadnyk; P J Myler; K Stuart
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  Specific binding of angiogenin to calf pulmonary artery endothelial cells.

Authors:  J Badet; F Soncin; J D Guitton; O Lamare; T Cartwright; D Barritault
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 6.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

7.  Modular mutagenesis of human placental ribonuclease inhibitor, a protein with leucine-rich repeats.

Authors:  F S Lee; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 8.  Function and regulation of class II transactivator in the immune system.

Authors:  Cheong-Hee Chang; Tania S Gourley; Tyler J Sisk
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

9.  A ribonuclease inhibitor expresses anti-angiogenic properties and leads to reduced tumor growth in mice.

Authors:  I J Polakowski; M K Lewis; V R Muthukkaruppan; B Erdman; L Kubai; R Auerbach
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

10.  The CCR4 protein from Saccharomyces cerevisiae contains a leucine-rich repeat region which is required for its control of ADH2 gene expression.

Authors:  T Malvar; R W Biron; D B Kaback; C L Denis
Journal:  Genetics       Date:  1992-12       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.